News archive for Translational Cancer Research

Phase 1B/II clinical trial for glioblastoma (10.11.2017)

Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy

March 2021 (1)
October 2020 (2)
April 2020 (1)
December 2018 (1)
November 2018 (1)
November 2017 (1)
July 2016 (1)